ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 145 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $18,705,000 | +9.4% | 1,183,835 | -12.1% | 0.68% | +1.2% |
| Q1 2018 | $17,095,000 | +3.2% | 1,346,049 | -7.0% | 0.67% | +1.7% |
| Q4 2017 | $16,567,000 | +6.4% | 1,446,865 | +13.9% | 0.66% | +1.5% |
| Q3 2017 | $15,564,000 | +44.2% | 1,270,555 | +34.8% | 0.65% | +37.8% |
| Q2 2017 | $10,794,000 | +24.2% | 942,709 | +125.5% | 0.47% | +18.3% |
| Q1 2017 | $8,694,000 | 0.0% | 417,963 | 0.0% | 0.40% | -3.9% |
| Q4 2016 | $8,694,000 | +45.1% | 417,963 | +74.2% | 0.41% | +23.2% |
| Q2 2016 | $5,990,000 | – | 239,889 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |